Advanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called ...

Discover the study supports the potential of neoadjuvant androgen deprivation therapy as an adjunctive therapy in HRLPC.

Precision Drug Olaparib May Be Effective Without Hormone Therapy for Some Men With Biochemically Recurrent Prostate Cancer Aug. 22, 2024 — The anti-cancer drug olaparib may be effective in ...

King Charles ’ health is on the mend. After being diagnosed with cancer last February, the monarch, 76, began undergoing ...

Gozetotide is a drug for diagnostic application in adults with prostate cancer. It is currently the only diagnostic agent that recognizes PSMA-positive prostate cancer and can therefore identify ...

Abiraterone is under clinical development by Austhera BioSciences and currently in Phase II for Hormone-Sensitive Prostate Cancer.

Source Reference: Gudenkauf LM, et al "Balancing hormone therapy: Mitigating adverse effects of androgen-deprivation therapy and exploring alternatives in prostate cancer management" Am Soc Clin ...

Dalpiciclib is under clinical development by Jiangsu Hengrui Medicine and currently in Phase III for Hormone-Sensitive Prostate Cancer.

King Charles is holding steady with his cancer treatment. PEOPLE reports that palace sources say his treatments will continue ...

understanding and recognizing potential warning signs can lead to earlier detection and more effective treatment outcomes.

Prostate cancer cells rely on testosterone to help them grow. Hormone therapy, a treatment to stop your body from producing testosterone, is often used to shrink advanced prostate cancer and slow ...